Registry for patients treated for Status Epilepticus

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

SENSE-II/AROUSE is a prospective, multicenter registry aimed at documenting the characteristics, treatment modalities, EEG features, and outcomes of adults admitted for Status Epilepticus (SE) across various medical centers in Europe. The study will collect clinical and EEG data from patient admission to discharge using electronic data capture tools. By including both university and non-university hospitals, the study seeks to enhance the generalizability of its findings and identify predictors of outcomes and refractoriness in SE management. A target cohort size of 3000 patients is set to ensure sufficient statistical power for analysis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients aged 18 years or above
* Patients admitted for management of Status Epilepticus as their primary diagnosis
* Patients admitted for another primary diagnosis but identified with Status Epilepticus during their acute hospital stay

Exclusion Criteria:

\- Patients with post-cardiac arrest SE

Where it's running

• HUB Erasme
  Brussels, Belgium Recruiting
• Odense University Hospital & Svenborg Hospital
  Odense, Denmark Recruiting
• Kepler University Linz
  Linz, Austria Not yet recruiting
• Christian Doppler Klinik of Paracelsus Medical University
  Salzburg, Austria Not yet recruiting
• Helsinki University Central Hospital
  Helsinki, Finland Not yet recruiting
• Goethe-Universität Frankfurt am Main
  Frankfurt, Germany Not yet recruiting

Study contacts

• Principal investigator: Nicolas Gaspard, MD, PhD — Erasme UH
• Study coordinator: Nicolas Gaspard, MD, PhD
• Email: Nicolas.Gaspard@erasme.ulb.ac.be
• Phone: 00325553429

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Recovery after coma from serious brain injury or illness

  This observational study will follow adults who are unconscious due to a serious brain illness or injury to see what medical, neurological, psychological, and social factors are linked with recovery over time.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07614074

• Augmented kidney clearance in neurocritical care

  This project will test whether adults in the neuro-ICU with severe brain injury, stroke, seizures, or brain infections have faster kidney clearance (ARC) that can lower antiseizure and antibiotic drug levels.

  Recruiting at 3 sites University of Alberta · Lexington, Kentucky and 2 other locations · NCT07410624

• Ketamine added to levetiracetam to stop prolonged convulsive seizures

  This trial will test whether giving ketamine (two different doses) along with levetiracetam helps stop benzodiazepine-refractory status epilepticus in people age 1 and older.

  Recruiting at 36 sites Phase 3 University of Virginia · Birmingham, Alabama and 62 other locations · NCT06907173

• Improving prognosis for patients with Status Epilepticus

  This study is trying to find blood markers that can help predict how well patients with Status Epilepticus will recover in the ICU and how their thinking skills may change after they leave the hospital.

  Recruiting London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · London, Ontario · NCT06590883

• Using Rapid-Response EEG to Diagnose Seizures in Children

  This study is testing if a new quick EEG device can help doctors diagnose seizures in children faster than the standard method.

  Recruiting Children's Hospital at Montefiore · The Bronx, New York · NCT06564662

• Two-way video support for paramedics caring for infants with life-threatening breathing problems.

  This project will test whether a two-way video link with pediatric emergency doctors helps paramedics give better care to infants with life-threatening breathing problems during transport.

  Recruiting at 4 sites Boston Medical Center · Los Angeles, California and 8 other locations · NCT06441760

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.